BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodrigues LS, Fagotti J, D.s. Targa A, D. Noseda AC, L. Ilkiwa J, Chuproski AP, W.c. Dorieux F, D. dos Santos P, M.s. Lima M. Potential new therapies against a toxic relationship: neuroinflammation and Parkinson’s disease. Behavioural Pharmacology 2019;30:675-87. [DOI: 10.1097/fbp.0000000000000512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Boullon L, Abalo R, Llorente-berzal Á. Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment. Front Pharmacol 2021;12:734613. [DOI: 10.3389/fphar.2021.734613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Hu XL, Lv XY, Wang R, Long H, Feng JH, Wang BL, Shen W, Liu H, Xiong F, Zhang XQ, Ye WC, Wang H. Optimization of N-Phenylpropenoyl-l-amino Acids as Potent and Selective Inducible Nitric Oxide Synthase Inhibitors for Parkinson's Disease. J Med Chem 2021;64:7760-77. [PMID: 34019417 DOI: 10.1021/acs.jmedchem.1c00578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 He D, Fu S, Zhou A, Su Y, Gao X, Zhang Y, Huang B, Du J, Liu D. Camptothecin Regulates Microglia Polarization and Exerts Neuroprotective Effects via Activating AKT/Nrf2/HO-1 and Inhibiting NF-κB Pathways In Vivo and In Vitro. Front Immunol 2021;12:619761. [PMID: 33868235 DOI: 10.3389/fimmu.2021.619761] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
4 Reiter RJ, Rosales-Corral S, Sharma R. Circadian disruption, melatonin rhythm perturbations and their contributions to chaotic physiology. Adv Med Sci 2020;65:394-402. [PMID: 32763813 DOI: 10.1016/j.advms.2020.07.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]